Cargando…

Progress on diagnostic and prognostic markers of pancreatic cancer

Pancreatic cancer is a malignant disease characterized by low survival and high recurrence rate, whose patients are mostly at the stage of locally advanced or metastatic disease when first diagnosed. Early diagnosis is particularly important because prognostic/predictive markers help guide optimal i...

Descripción completa

Detalles Bibliográficos
Autores principales:	YANG, HONG, LI, WAN, REN, LIWEN, YANG, YIHUI, ZHANG, YIZHI, GE, BINBIN, LI, SHA, ZHENG, XIANGJIN, LIU, JINYI, ZHANG, SEN, DU, GUANHUA, TANG, BO, WANG, HONGQUAN, WANG, JINHUA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tech Science Press 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208033/ https://www.ncbi.nlm.nih.gov/pubmed/37304241 http://dx.doi.org/10.32604/or.2023.028905

Ejemplares similares

GABRP is a potential prognostic biomarker and correlated with immune infiltration and tumor microenvironment in pancreatic cancer
por: Yang, Yihui, et al.
Publicado: (2022)

CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis
por: Ren, Liwen, et al.
Publicado: (2022)

Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB /IL-6/STAT3 and JNK/PTX3 pathways
por: Li, Wan, et al.
Publicado: (2022)

Recent advances in epigenetic anticancer therapeutics and future perspectives
por: Ren, Liwen, et al.
Publicado: (2023)

Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
por: Li, Sha, et al.
Publicado: (2022)

ERCC6L facilitates the onset of mammary neoplasia and promotes the high malignance of breast cancer by accelerating the cell cycle
por: Yang, Hong, et al.
Publicado: (2023)

The biology, function, and applications of exosomes in cancer
por: Liu, Jinyi, et al.
Publicado: (2021)

Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway
por: Zheng, Xiangjin, et al.
Publicado: (2021)

MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma
por: Tang, Qin, et al.
Publicado: (2020)

Apolipoproteins and cancer
por: Ren, Liwen, et al.
Publicado: (2019)

Withaferin A triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4‐ATF3‐CHOP axis
por: Tang, Qin, et al.
Publicado: (2019)

3-O-Acetyl-11-keto-β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma
por: Li, Wan, et al.
Publicado: (2020)

A narrative review of research progress on drug therapies for glioblastoma multiforme
por: Zheng, Xiangjin, et al.
Publicado: (2021)

3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase
por: Li, Wan, et al.
Publicado: (2018)

Correction: 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase
por: Li, Wan, et al.
Publicado: (2022)

Ganglioside GD3 synthase (GD3S), a novel cancer drug target
por: Liu, Jinyi, et al.
Publicado: (2018)

Research progress on the forkhead box C1
por: Wang, Jinhua, et al.
Publicado: (2017)

miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway
por: Li, Wan, et al.
Publicado: (2018)

Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway
por: Li, Wan, et al.
Publicado: (2022)

Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
por: Zhang, Weihong, et al.
Publicado: (2021)

A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma
por: Yu, Yang, et al.
Publicado: (2018)

Identification of CKS1B as a prognostic indicator and a predictive marker for immunotherapy in pancreatic cancer
por: Li, Lincheng, et al.
Publicado: (2022)

Leukocyte CH25H is a potential diagnostic and prognostic marker for lung adenocarcinoma
por: Zhang, Jun, et al.
Publicado: (2022)

Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer
por: Wan, Xuechao, et al.
Publicado: (2016)

GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma
por: Yang, Sen, et al.
Publicado: (2022)

KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma
por: Li, Wen-Chao, et al.
Publicado: (2019)

GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses
por: Zhang, Youfu, et al.
Publicado: (2021)

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
por: Wang, Yizhi, et al.
Publicado: (2020)

Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma
por: Cheng, Yang, et al.
Publicado: (2019)

Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma
por: Li, Qing, et al.
Publicado: (2016)

USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration
por: Wang, Yizhi, et al.
Publicado: (2022)

RAC1, a Potential Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma
por: Wu, Xue, et al.
Publicado: (2022)

SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis
por: Huang, Jianhua, et al.
Publicado: (2021)

Prognostic analysis and validation of diagnostic marker genes in patients with osteoporosis
por: Wang, Xing, et al.
Publicado: (2022)

Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer
por: Ou, Zheng-Lin, et al.
Publicado: (2019)

Integrating Genetic and Transcriptomic Data to Reveal Pathogenesis and Prognostic Markers of Pancreatic Adenocarcinoma
por: Bai, Kaisong, et al.
Publicado: (2021)

DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer
por: Cao, Meng, et al.
Publicado: (2021)

Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer
por: Pang, Li, et al.
Publicado: (2016)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
por: Zuo, Duo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6havvi1spd0f5p0u7s6ik24jon